Clinical Trial Update: Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

View source ↗

Summary

This clinical trial entry describes an ongoing study investigating how N-glycosylation contributes to AL amyloidosis, including its molecular basis, diagnostic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: AL Amyloidosis, MGUS | Status: RECRUITING